Filing Flows › Koninklijke Philips NV (PHG) › Recalls, complaints & regulation
Koninklijke Philips NV (PHG): recalls and clinical trials
Koninklijke Philips NV (PHG) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I); 27 active clinical trials.
Latest recalls
- 2023-08-03 · CPSC · Philips Avent Digital Video Baby Monitors Recalled by Philips Personal Health Due to Burn Hazard
Koninklijke Philips NV's latest quarter
Koninklijke Philips NV, Q3 2026: revenue $4.4B (+2% year over year), operating margin 3.8%, net earnings $28.0M, operating cash flow $544M. The chart follows the revenue to costs, profit and cash.
Questions
Has Koninklijke Philips NV had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
How many clinical trials does Koninklijke Philips NV have?
27 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.